Pilot study to evaluate response prediction using ctDNA in women undergoing platinum-based chemotherapy or PARP inhibitor treatment for metastatic breast and ovarian cancer.

Complete Title: Pilot study to evaluate response prediction using ctDNA in women undergoing platinum-based chemotherapy or PARP inhibitor treatment for metastatic breast and ovarian cancer.
Trial Phase: N/A
Investigator: Kalyan Banda

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

N/A
Kalyan Banda
RG1004008
Pilot study to evaluate response prediction using ctDNA in women undergoing platinum-based chemotherapy or PARP inhibitor treatment for metastatic breast and ovarian cancer.